The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

C Gordon, MB Amissah-Arthur, M Gayed… - …, 2018 - academic.oup.com
Caroline Gordon1, 2, 3, Maame-Boatemaa Amissah-Arthur1, Mary Gayed1, 3, Sue Brown4,
Ian N. Bruce5, 6, David D'Cruz7, Benjamin Empson8, Bridget Griffiths9, David Jayne10, 11 …

Atherosclerosis in rheumatoid arthritis: is it all about inflammation?

S Skeoch, IN Bruce - Nature Reviews Rheumatology, 2015 - nature.com
Rheumatoid arthritis (RA) has long been associated with increased cardiovascular risk, but
despite substantial improvements in disease management, mortality remains high …

[HTML][HTML] Drug-induced interstitial lung disease: a systematic review

S Skeoch, N Weatherley, AJ Swift, A Oldroyd… - Journal of clinical …, 2018 - mdpi.com
Background: Drug-induced interstitial lung disease (DIILD) occurs as a result of numerous
agents, but the risk often only becomes apparent after the marketing authorisation of such …

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

M Petri, AM Orbai, GS Alarcón, C Gordon… - Arthritis & …, 2012 - Wiley Online Library
Abstract Objective The Systemic Lupus International Collaborating Clinics (SLICC) group
revised and validated the American College of Rheumatology (ACR) systemic lupus …

Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

S Nejentsev, JMM Howson, NM Walker, J Szeszko… - Nature, 2007 - nature.com
The major histocompatibility complex (MHC) on chromosome 6 is associated with
susceptibility to more common diseases than any other region of the human genome …

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

RF Van Vollenhoven, M Mosca, G Bertsias… - Annals of the …, 2014 - ard.bmj.com
The principle of treating-to-target has been successfully applied to many diseases outside
rheumatology and more recently to rheumatoid arthritis. Identifying appropriate therapeutic …

[HTML][HTML] Trial of anifrolumab in active systemic lupus erythematosus

EF Morand, R Furie, Y Tanaka, IN Bruce… - … England Journal of …, 2020 - Mass Medical Soc
Background Anifrolumab, a human monoclonal antibody to type I interferon receptor subunit
1 investigated for the treatment of systemic lupus erythematosus (SLE), did not have a …

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) …

IN Bruce, AG O'Keeffe, V Farewell, JG Hanly… - Annals of the …, 2015 - ard.bmj.com
Background and aims We studied damage accrual and factors determining development
and progression of damage in an international cohort of systemic lupus erythematosus …

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study

IN Bruce, MB Urowitz, DD Gladman… - Arthritis & …, 2003 - Wiley Online Library
Objective Because women with systemic lupus erythematosus (SLE) are 5–8 times more
likely to develop coronary heart disease (CHD) than are women in the general population …

The frequency and outcome of lupus nephritis: results from an international inception cohort study

JG Hanly, AG O'Keeffe, L Su, MB Urowitz… - …, 2016 - academic.oup.com
Objective. To determine nephritis outcomes in a prospective multi-ethnic/racial SLE
inception cohort. Methods. Patients in the Systemic Lupus International Collaborating Clinics …